SPM
SPM ·HOSE ·2026Q1
▼▼ Declining sharply
TTM · Applied to: EPS, ROE, ROA, Net Margin, Asset Turnover, Debt/Equity
What Is Changing
On a TTM 2026Q1 basis, SPM is losing revenue quickly, though margins have not been hit proportionally yet — margins have been compressing consistently over multiple periods. This only holds if margins can continue to resist — if revenue stays weak, margin pressure will build.
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 46.0 | 48.1 | 57.7 | 65.6 | 82.5 | 73.2 | 73.7 | 72.1 | 78.9 | 78.9 | 102.1 | 125.1 |
| Growth | -4% | -17% | -12% | -20% | +13% | -1% | +2% | -9% | -0% | -23% | -18% | — |
| Net Income | 3.2 | -3.0 | 5.1 | 4.1 | 3.1 | 10.2 | 1.2 | 4.0 | 1.3 | 0.4 | 3.7 | 5.0 |
| Net Margin | 6.99% | -6.29% | 8.79% | 6.27% | 3.82% | 13.90% | 1.66% | 5.56% | 1.60% | 0.48% | 3.64% | 4.01% |
Drivers of SPM's profit
Net profit attributable to parent declined vs last year, mainly due to higher administrative expenses. Supporting and offsetting drivers:
Net profit attributable to parent increased vs prior quarter, mainly helped by lower selling expenses. Supporting and offsetting drivers:
Financial Highlights
Detailed analysis of each financial dimension
ROE = Profit Margin × Asset Turnover × Equity Multiplier
ROE fell from 2.3% to 1.2% — all three components weakened, with asset turnover being the main drag.
Is the profit sustainable?
Margins narrowed but earnings quality remains clean — pressure is mainly operational.
What is driving the margin?
Net margin fell to 4.31%, losing 1.8pp. The main pressure is SG&A / Revenue rose 6.6pp, outweighing the improvement in Gross margin rose 6.6pp (with lingering pressure from Other profit / Revenue fell 1.0pp and Net financial result / Revenue fell 0.1pp).
Margin is under pressure from multiple sides — temporary and structural components need to be separated to properly assess the risk.
Profitability trend
TTM YoY · 2025Q1 -> 2026Q1
Is capital being used efficiently?
Evaluate capital, asset, and working-capital efficiency.
Is capital being deployed efficiently?
ROIC narrowed to 1.18%, falling 0.8pp. That translates to 1.18 in after-tax operating profit for every 100 units of operating capital. Both NOPAT margin narrowed 1.1pp and capital turnover fell 0.08x, with invested capital holding roughly steady — pressure came from both operational efficiency and asset efficiency.
Both margin and turnover weakened — this is a broad-based decline, and cyclical versus structural components need to be separated.
Watchpoints
ROIC is currently 1.18% — below the typical cost-of-capital threshold; worth tracking whether upcoming periods can rise above this level.
CAPITAL EFFICIENCY TREND
TTM YoY · 2025Q1 -> 2026Q1
Balance Sheet
Capital structure is conservative with low leverage — liabilities at 0.17x equity, net debt at 0.10x equity.
Over the last 12 months, working capital released 17.9bn of cash, mainly thanks to lower receivables and higher payables. Pressure from higher inventories only partly offset that benefit.
Working Capital Drivers
TTM YoY · 2025Q1 -> 2026Q1
Working Capital Efficiency
Cash conversion cycle lengthened by 381.7 days versus the same period last year. The main moves came from DIO rose 49.0 days, DSO rose 351.9 days, and DPO rose 19.2 days.
Working capital cycle lengthened mainly due to slower receivables collection — receivables quality needs monitoring.
Watchpoints
CCC stands at 1385.2 days, suggesting that working capital remains tied up for a relatively long operating cycle.
DSO increased by +351.9 days, pointing to slower receivables turnover.
Working Capital Efficiency
TTM YoY · 2025Q1 -> 2026Q1
Is financial risk significant?
Financial risk is low — leverage is safe, both CFO and FCF are positive.
Leverage & Liquidity
Leverage is balanced for now, with net debt / equity at 0.10x and interest coverage at 2.31x.
At present, short-term debt accounts for 100.0% of total debt, cash equals 2.4% of debt, and total debt stands at 85.3bn.
Watchpoints
Short-term debt accounts for 100.0% of total debt, raising near-term refinancing needs.
Cash / debt stands at 2.4%, leaving limited liquidity buffer to monitor.
Leverage and liquidity trend
TTM YoY · 2025Q1 -> 2026Q1
Cash Flow
With safe leverage noted above, cash flow below shows the self-funding capacity. Operating cash flow reached 62.0bn in 2025, against investing cash flow of -12.0bn.
Post-investment cash flow was positive +50.0bn. Financing cash flow was negative +77.4bn.
CFO / net income was 6.51x.
After spending +11.1bn on fixed-asset investment, the business generated trailing free cash flow of +50.0bn.
Cash Conversion
TTM Cash Conversion · 2025Q1 -> 2026Q1
Investment Takeaway
The business is showing a few weaker signals, but the current magnitude is not yet clear enough to conclude that this is a broader weakening phase. The brighter spot is earnings conversion is confirmed, with CFO/NI at 6.51x. The main risk still sits in core profitability, with net margin down 1.8 pp.
Improvement: earnings conversion looks more confirmed, with CFO / net income at 6.51x.
Key risk: profitability remains under pressure, with trailing-12M net margin at 4.31% after a 1.8pp decline versus the same period last year.
Statement Data
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
|
Net Revenue
|
254.0 | 297.8 | 406.1 | 697.2 | 709.9 |
|
Cost of Goods Sold
|
193.1 | 237.1 | 336.4 | 617.2 | 0.0 |
|
Gross Profit
|
60.9 | 60.7 | 69.7 | 80.0 | 84.9 |
|
Financial Expenses
|
6.5 | 7.7 | 12.1 | 11.9 | -12.4 |
|
Selling Expenses
|
19.3 | 23.2 | 22.9 | 22.9 | -33.0 |
|
General and Administrative Expenses
|
35.3 | 26.2 | 16.3 | 15.3 | -13.3 |
|
Operating Profit
|
0.3 | 3.7 | 18.8 | 30.8 | 26.4 |
|
Profit Before Tax
|
-0.1 | 4.1 | 16.5 | 30.5 | 26.2 |
|
Net Income
|
-1.7 | 4.6 | 12.1 | 23.9 | 20.2 |
|
Profit Attributable to Parent
|
-1.7 | 4.6 | 12.1 | 23.9 | 20.2 |
|
Earnings per Share
|
-123.00 | 335.00 | 880.00 | 1,735.00 | 1,466.00 |
Explore Other Stocks In The Same Sector
DHG, DVN, IMP, DBD, DTP, TRA, DMC, DP3, OPC, NDC, DAN, PMC, VDP, DHT, FIT, DHD, AGP, DVM, CNC, PBC, LDP, DPH, VMD, NDP, HDP, DCL, PPP, VET, MTP, MKV, DHN, MED, DBT, DTG, DPP, BIO, VNY, DBM, MKP, TW3, DTH, NTF, BCP, UPH, DP2, VXP
Need support? If you need support with content lookup or want to provide feedback about content on the website, please contact us below.